Persistent infection with high-risk human papillomaviruses (HPVs), such as HPV-16 and
HPV-18, can induce cervical cancer in humans. The disease carries high morbidity and …

Recent studies have shown that cancer immunotherapy could be a promising therapeutic
approach for the treatment of cancer. In the present study, to identify novel tumor-associated …

Human Papillomavirus 16 (HPV-16) has been identified as the causative agent of 50% of
cervical cancers and many other HPV-associated tumors. The transforming potential/tumor …

Human papilloma virus type 16 (HPV16) is the most prevalent etiologic agent associated
with cervical cancer, and its early proteins E5, E6 and E7 play important roles in cervical …

Cervical cancer is a common type of cancer among women worldwide and infection with
high-risk human papillomavirus (HPVs) types represents the major risk factor for the …

Human Papillomavirus (HPV) is a widely distributed and common virus, that causes benign
lesions (such as warts and papillomas) but, if not cleared, can lead to malignant lesions as …

Human papillomavirus type 16 (HPV-16) is the most prevalent virus in human cervical
cancers, as it is present in more than half of all cases. Many studies have found continued …

Protein degradation by proteasome is essential to the regulation of important cellular
functions including cell cycle progression, proliferation, differentiation and apoptosis …

Human papillomaviruses (HPVs) are a group of circular double-stranded DNA viruses,
showing severe tropism to mucosal tissues. A subset of HPVs, especially HPV16 and 18, are …

Conventional immunoprecipitation/mass spectroscopy identification of HLA-restricted
peptides remains the purview of specializing laboratories, due to the complexity of the …